Ha habido 50 transacciones internas recientes registradas para Eliem Therapeutics, Inc. (ELYM), incluyendo 28 compras y 19 ventas. El total de compras internas fue valorado en $757.2K y el total de ventas internas en $3.17M.
Internos destacados con actividad reciente incluyen Pimblett Emily, Kaplan Brett, Morisset Valerie. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ELYM
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-09-20 |
Pimblett Emily |
Chief Accounting Officer |
Venta Informativa |
9 |
$8.06 |
$72.54 |
7,564 |
| 2024-09-18 |
Pimblett Emily |
Chief Accounting Officer |
Ejercicio de Opciones |
5,000 |
- |
- |
8,755 |
| 2024-08-26 |
Kaplan Brett |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-08-26 |
Kaplan Brett |
Chief Operating Officer |
Concesión de RSU |
77,500 |
- |
- |
77,500 |
| 2024-07-22 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
30,000 |
$7.98 |
$239.4K |
31,317 |
| 2024-07-19 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$7.24 |
$362K |
100,322 |
| 2024-07-18 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
38,576 |
$6.93 |
$267.33K |
160,523 |
| 2024-07-17 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
3,207 |
$6.91 |
$22.16K |
199,099 |
| 2024-07-16 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$7.13 |
$356.5K |
202,306 |
| 2024-07-15 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
42,377 |
$7.01 |
$297.06K |
252,306 |
| 2024-07-12 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$7.07 |
$353.5K |
294,683 |
| 2024-07-11 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$7.11 |
$355.5K |
344,683 |
| 2024-07-10 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$6.83 |
$341.5K |
394,683 |
| 2024-07-09 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
5,931 |
$6.66 |
$39.5K |
444,683 |
| 2024-07-05 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
12,342 |
$7.06 |
$87.13K |
450,614 |
| 2024-07-03 |
Morisset Valerie |
EVP, R&d and CSO |
Venta Informativa |
50,000 |
$6.76 |
$338K |
462,956 |
| 2024-07-01 |
Morisset Valerie |
EVP, R&d and CSO |
Ejercicio de Opciones (Venta) |
7,649 |
$0.00 |
$1.53 |
10,198 |
| 2024-06-27 |
Brennan Aoife |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-27 |
Brennan Aoife |
President and CEO |
Concesión de RSU |
275,000 |
- |
- |
275,000 |
| 2024-06-27 |
Thomas Stephen Basil |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-27 |
Thomas Stephen Basil |
Director |
Concesión de RSU |
100,375 |
- |
- |
100,375 |
| 2024-06-27 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
1,807,000 |
- |
- |
1,807,000 |
| 2024-06-26 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Ratcliffe Liam |
Director |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Dunn Judith |
Director |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Rosenberg Adam Joseph |
Director |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Tate Simon |
Director |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-26 |
Levin Andrew David |
Executive Chairman |
Concesión de RSU |
10,000 |
$7.89 |
$78.9K |
10,000 |
| 2024-06-20 |
Pimblett Emily |
Chief Accounting Officer |
Venta Informativa |
1,245 |
$7.21 |
$8.98K |
3,755 |
| 2024-06-18 |
Pimblett Emily |
Chief Accounting Officer |
Ejercicio de Opciones |
5,000 |
- |
- |
5,000 |
| 2024-04-05 |
Morisset Valerie |
EVP, R&d and CSO |
Ejercicio de Opciones (Venta) |
17,847 |
$0.00 |
$3.57 |
28,046 |
| 2024-03-18 |
Pimblett Emily |
Chief Accounting Officer |
Ejercicio de Opciones |
40,000 |
- |
- |
40,000 |
| 2023-09-20 |
Morisset Valerie |
EVP, R&d and CSO |
Ejercicio de Opciones (Venta) |
5,431 |
$0.00 |
$10.86 |
- |
| 2023-05-18 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Ratcliffe Liam |
Director |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Dunn Judith |
Director |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Rosenberg Adam Joseph |
Director |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Tate Simon |
Director |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-05-18 |
Levin Andrew David |
Executive Chairman |
Concesión de RSU |
10,000 |
$3.00 |
$30K |
10,000 |
| 2023-03-13 |
Pimblett Emily |
Chief Accounting Officer |
Disposición |
30,000 |
$3.27 |
$98.1K |
- |
| 2023-03-10 |
Morisset Valerie |
EVP, R&d and CSO |
Ejercicio de Opciones (Venta) |
255,219 |
$0.00 |
$510.44 |
5,431 |
| 2022-10-31 |
Azelby Robert |
President & CEO |
Concesión de RSU |
500,000 |
- |
- |
500,000 |
| 2022-10-31 |
Bucher James B |
EVP and General Counsel |
Concesión de RSU |
95,000 |
- |
- |
95,000 |
| 2022-10-31 |
Lavelle Erin |
COO & CFO |
Concesión de RSU |
170,000 |
- |
- |
170,000 |
| 2022-10-31 |
Morisset Valerie |
EVP, R&d and CSO |
Concesión de RSU |
170,000 |
- |
- |
170,000 |
| 2022-05-19 |
Patterson Leone D |
Director |
Concesión de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Ra Capital Management, L.p. |
10 Percent Owner |
Concesión de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Ratcliffe Liam |
Director |
Concesión de RSU |
10,000 |
$3.46 |
$34.6K |
10,000 |
| 2022-05-19 |
Shah Rajeev M. |
Director |
Concesión de RSU |
10,000 |
- |
- |
10,000 |
| 2022-05-19 |
Dunn Judith |
Director |
Concesión de RSU |
10,000 |
- |
- |
10,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
